This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Ewha University-Industry Collaboration Foundation, Lg Electronics Inc.. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2019-2026
Title: Hae Seung Lee - Innovator in Drug Virtual Screening
Introduction
Hae Seung Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of drug discovery through his innovative methods and systems. His work focuses on enhancing the accuracy of virtual drug screening, which is crucial for the development of new pharmaceuticals.
Latest Patents
Hae Seung Lee holds a patent for a "Method and system for drug virtual screening and construction of focused screening library." This invention relates to a virtual drug screening method that boasts high prediction accuracy based on various biological activities extracted from multiple drug screening data. Notably, it does this without relying on the structures or structural attribute information of target proteins or compounds. The patent also includes a method for constructing an intensive screening library and the system that supports this process.
Career Highlights
Hae Seung Lee is affiliated with the Ewha University-Industry Collaboration Foundation, where he continues to advance research in drug screening technologies. His work is instrumental in bridging the gap between academic research and practical applications in the pharmaceutical industry.
Collaborations
Hae Seung Lee collaborates with notable colleagues, including Wan Kyu Kim and Yea Jee Kwon, who contribute to his research endeavors. Their combined expertise enhances the development of innovative solutions in drug discovery.
Conclusion
Hae Seung Lee's contributions to drug virtual screening represent a significant advancement in the field of pharmaceuticals. His innovative methods and collaborative efforts continue to pave the way for more effective drug discovery processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile